Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04321603

Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Maryland, Baltimore · Academic / Other
Sex
All
Age
50 Years – 65 Years
Healthy volunteers
Not accepted

Summary

People living with HIV are living longer as their disease is controlled with antiretroviral medications. Yet they are experiencing frailty more often and more than ten years earlier than those without HIV. In elderly persons without HIV, frailty is associated with decreased muscle strength and chronic inflammation. Less is known about what is driving early frailty in HIV or effective prevention measures for aging adults with HIV. It may be that having HIV infection impairs energy production by mitochondria within the cells and contributes to the muscle weakness and inflammation accompanying frailty in people living with HIV . This study will examine the impact of six weeks of moderately paced walking on energy production in the cells, inflammation markers and frailty scores in people living with well-controlled HIV who are aged 50 to 65.

Conditions

Interventions

TypeNameDescription
BEHAVIORALWalkingModerately paced walking of approximately 100 steps/minute for 30 minutes three times weekly for six weeks.

Timeline

Start date
2020-05-30
Primary completion
2020-05-30
Completion
2020-05-30
First posted
2020-03-25
Last updated
2021-08-11

Source: ClinicalTrials.gov record NCT04321603. Inclusion in this directory is not an endorsement.